Umbilical cord-derived mesenchymal stromal cells(University of Louisville)(Umbilical cord-derived mesenchymal stromal cells(University of Louisville))

概要

基本信息

药物类型

间充质干细胞疗法

别名-

靶点-

作用机制-

治疗领域

心血管疾病

在研适应症

缺血性心肌病心肌缺血

非在研适应症-

原研机构

University of Louisville

在研机构

University of Louisville

非在研机构-

最高研发阶段临床2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

1

项与 Umbilical cord-derived mesenchymal stromal cells(University of Louisville) 相关的临床试验

NCT06145035 / Recruiting临床2期IIT

University of Louisville - 18642 / CATO Study, Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy

This is a Phase IIA, randomized, double blind, placebo controlled, multicenter study designed to assess the safety, feasibility, and efficacy of umbilical cord derived mesenchymal stromal cells (UC MSCs), administered intravenously (IV) as a single dose or repeated doses, in patients with ischemic cardiomyopathy (ICM).

开始日期2024-03-04

申办/合作机构

University of Louisville

[+2]

100 项与 Umbilical cord-derived mesenchymal stromal cells(University of Louisville) 相关的临床结果

登录后查看更多信息

100 项与 Umbilical cord-derived mesenchymal stromal cells(University of Louisville) 相关的转化医学

登录后查看更多信息

100 项与 Umbilical cord-derived mesenchymal stromal cells(University of Louisville) 相关的专利（医药）

登录后查看更多信息

100 项与 Umbilical cord-derived mesenchymal stromal cells(University of Louisville) 相关的药物交易

登录后查看更多信息